Figure 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
<p>Flow chart of study population. Note: Extending adjuvant hormone therapy was defined as continuing the therapy for ≥6 months and filling ≥2 prescriptions of tamoxifen or aromatase inhibitors beyond the 5-year adjuvant hormone therapy.</p>
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Drugi avtorji: | , , , |
| Izdano: |
2025
|
| Teme: | |
| Oznake: |
Označite
Brez oznak, prvi označite!
|